EcoDrugPlus

Leukotriene A4 Hydrolase

Ensembl ID : ENSLOCG00000015731
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSLOCG00000004475
Gene Symbol: KDM1A
3 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSLOCG00000015445
Gene Symbol: LOXL2
3 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSLOCG00000006798
Gene Symbol: MIF
3 Cross references
225 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSLOCG00000010867
Gene Symbol: MST1R
3 Cross references
193 Possible Orthologues:

Matrix Metallopeptidase 13a

Ensembl ID : ENSLOCG00000001156
Gene Symbol: MMP13A
1 Cross references
307 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSLOCG00000007073
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSLOCG00000001263
Gene Symbol: MMP7
3 Cross references
104 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSLOCG00000006863
Gene Symbol: MMP9
1 Cross references
215 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSLOCG00000006342
Gene Symbol: MTOR
3 Cross references
220 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSLOCG00000001220
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSLOCG00000018357
Gene Symbol: MC3R
1 Cross references
138 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).